Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: A multi-method study

Health Policy

Volumn 88, Issue 2-3, 2008, Pages 258-268

  Bradley, Fay ^a   Wagner, Andrew C ^a   Elvey, Rebecca ^a   Noyce, Peter R ^a   Ashcroft, Darren M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Community pharmacy services; England; Health care delivery; Medicines use review; Policy development

Indexed keywords

ARTICLE; GENERAL PRACTITIONER; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HEALTH SURVEY; PHARMACY; PRIMARY MEDICAL CARE; UNITED KINGDOM;

ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; DRUG UTILIZATION REVIEW; ENGLAND; HEALTH CARE SURVEYS; POLICY MAKING; STATE MEDICINE;

EID: 47649132910     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2008.03.013     Document Type: Article

References (30)

1. Noyce P.R. Providing patient care through community pharmacies in the UK: policy, practice, and research. The Annals of Pharmacotherapy 41 5 (2007) 861-868
2. Department of Health. Pharmacy in the future: implementing the NHS plan (2000), The Stationery Office, London
3. Department of Health. A vision for pharmacy in the new NHS (2003), The Stationery Office, London
4. Pharmaceutical Services Negotiating Committee. The new contract for community pharmacy (2004), PSNC, Aylesbury
5. Pharmaceutical Services Negotiating Committee. NHS community pharmacy contractual framework advanced service-medicines use review and prescription intervention service, service specification (2008), PSNC, Aylesbury
6. Department of Health. Reorganisation of ambulance trusts, strategic health authorities and primary care trusts. Available at: http://www.dh.gov.uk/en/Policyandguidance/Organisationpolicy/Healthreform/DH_4135663. Accessed on 29-1-2008.
7. Elvey R., Bradley F., Ashcroft D., and Noyce P. Commissioning services and the new pharmacy contract. (1). Pharmaceutical needs assessments and uptake of new pharmacy contracts. The Pharmaceutical Journal 277 (2006) 161-163
8. Bradley F., Elvey R., Ashcroft D., and Noyce P. Commissioning services and the new community pharmacy contract. (2). Drivers, barriers and approaches to commissioning. The Pharmaceutical Journal 277 (2006) 189-192
9. Bradley F., Elvey R., Ashcroft D., and Noyce P. Commissioning services and the new community pharmacy contract. (3). Uptake of enhanced services. The Pharmaceutical Journal 277 (2006) 224-226
10. Elvey R., Bradley F., Ashcroft D., and Noyce P. Commissioning services and the new community pharmacy contract. (4). Governance and performance management. The Pharmaceutical Journal 277 (2006) 251-253
11. Department of Health. The pharmaceutical services (advanced and enhanced services) (England) directions 2005 (2005), The Stationary Office, London
12. Department of Health. The pharmaceutical services (advanced and enhanced services) (England) amendment directions 2006 (2006), The Stationary Office, London
13. National Health Services England and Wales. Advanced services (pharmacy contractors) medicines use review and prescription intervention service, part VIC. Drug tariff January 2008 (2008), The Stationary Office, London
14. Strong M., Maheswaran R., Pearson T., and Fryers P.A. A method for modelling GP practice level deprivation scores using GIS. International Journal of Health Geographics 6 38 (2007)
15. Ashworth M. The relationship between social deprivation and the quality of primary care: a national survey using indicators from the UK quality and outcomes framework. The British Journal of General Practice 57 539 (2007) 441-448
16. Bentham G. Limiting long-term illness and its associations with mortality and indicators of social deprivation. Journal of Epidemiology and Community Health 49 Suppl. 2 (1995) 64
17. Walker A., O'Brien M., Traynor J., Fox K., Goddard E., and Foster K. Living in Britain. Results from the 2001 general household survey (2002), The Stationary Office, London
18. Lloyd D.C. Prescribing at the primary care group level: census data and prescribing indicators. Journal of Clinical Pharmacy and Therapeutics 26 2 (2001) 93-101
19. Ashworth M., Lea R., Gray H., Rowlands G., Gravelle H., and Majeed A. How are primary care organizations using financial incentives to influence prescribing?. Journal of Public Health 26 1 (2004) 48-51
20. Blenkinsopp A., Celino G., Bond C., and Inch J. Medicines use reviews: the first year of a new community pharmacy service. The Pharmaceutical Journal 278 (2007) 218-223
21. Pharmaceutical Services Negotiating Committee. Community pharmacy news: new contract funding guide (2005), PSNC, Aylesbury
22. Pharmaceutical Services Negotiating Committee. NHS statistics: MUR statistics. Available at: http://www.psnc.org.uk/pages/mur_statistics.html. Accessed on 29-1-2008.
23. Dingwall R., and Watson P. Small pharmacies and the NHS (2002), Trent Institute of Health Service Research, London
24. Tudor Hart J. The inverse care law. The Lancet 1 7696 (1971) 405-412
25. Victora C.G., Vaughan J.P., Barros F.C., Silva A.C., and Tomasi E. Explaining trends in inequities: evidence from Brazilian child health studies. The Lancet 356 9235 (2000) 1093-1098
26. Community Pharmacy Framework Collaborative. Community Pharmacy Framework Collaborative (CPFC): final report (2007), National Prescribing Centre, Liverpool
27. Morris C.J., Cantrill J., and Weiss M.C. GPs' attitudes to minor ailments. Family Practice 18 6 (2001) 581-585
28. Zillich A.J. Influential characteristics of physician/pharmacist collaborative relationships. The Annals of Pharmacotherapy 38 5 (2004) 764-770
29. Wilcock M., and Harding G. General practitioners' perceptions of medicines use reviews by pharmacists. The Pharmaceutical Journal 279 (2007) 501-503
30. Edmunds J., and Calnan M.W. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Social Science and Medicine 53 (2001) 943-955